Compare $BOLT vs $SNGX | Chartloom

Compare

$BOLT vs $SNGX

Bolt Biotherapeutics Inc · Soligenix Inc

BOLT

Bolt Biotherapeutics Inc

SNGX

Soligenix Inc

Compare $BOLT vs $SNGX

Comparing Bolt Biotherapeutics Inc and Soligenix Inc

BOLTBolt Biotherapeutics Inc

SNGXSoligenix Inc

BOLTBolt Biotherapeutics Inc

Market cap

$8M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

12.8%

YTD performance

-29.0%

52W performance

-35.8%

FCF yield

-399.6%

SNGXSoligenix Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-74.4%

52W performance

-79.9%

FCF yield

-180.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BOLT

SNGX

Detailed metrics comparison

BOLT

Bolt Biotherapeutics Inc

SNGX

Soligenix Inc

Market Cap

BOLT$8M

SNGX$5M

Enterprise Value

BOLT$-5M

SNGX$-4M

Price

BOLT$4.11

SNGX$0.36

P/E Ratio

BOLTN/A

SNGXN/A

P/S Ratio

BOLT1.68x

SNGX16.09x

EV/Sales

BOLT-1.06x

SNGX-3.76x

EV/EBITDA

BOLT0.00x

SNGX-1.54x

P/B Ratio

BOLT0.53x

SNGX1.20x

P/FCF Ratio

BOLTN/A

SNGXN/A

EV/FCF

BOLT0.16x

SNGX0.45x

PEG Ratio

BOLTN/A

SNGXN/A

Forward P/E (NTM)

BOLTN/A

SNGXN/A

Forward P/S (NTM)

BOLTN/A

SNGXN/A

Revenue (TTM)

BOLT$5M

SNGX$0

Revenue Growth (YoY)

BOLT12.8%

SNGXN/A

Forward Rev Growth

BOLT1650.0%

SNGX0.0%

Gross Margin (TTM)

BOLT0.0%

SNGX8.8%

Operating Margin (TTM)

BOLT0.0%

SNGX0.0%

EBITDA Margin (TTM)

BOLT-586.3%

SNGX0.0%

Net Margin (TTM)

BOLT-611.5%

SNGX0.0%

FCF Margin (TTM)

BOLT-671.0%

SNGXN/A

Net Income (TTM)

BOLT$-29M

SNGX$-10M

FCF (TTM)

BOLT$-32M

SNGX$-10M

EPS (TTM)

BOLT-$17.00

SNGX-$0.64

ROE (TTM)

BOLT-12623.0%

SNGX-18102.0%

ROA (TTM)

BOLT-5470.0%

SNGX-10792.0%

ROIC (TTM)

BOLT-12623.0%

SNGX-18102.0%

Cash

BOLT$13M

SNGX$10M

Debt

BOLT$0

SNGX$0

Net Cash/Debt

BOLT$13M

SNGX$10M

Current Ratio (TTM)

BOLT2.61x

SNGX2.77x

Quick Ratio (TTM)

BOLT2.26x

SNGX2.67x

Debt/Equity (TTM)

BOLT0.00x

SNGX0.00x

Debt/Assets (TTM)

BOLT0.0%

SNGX0.0%

Interest Coverage (TTM)

BOLTN/A

SNGXN/A

Net Debt/EBITDA (TTM)

BOLT0.00x

SNGX0.00x

Beta

BOLT0.97

SNGX2.15

52W Performance

BOLT-35.8%

SNGX-79.9%

YTD Performance

BOLT-29.0%

SNGX-74.4%

% from 52W High

BOLT-42.9%

SNGX-81.5%

% from 52W Low

BOLT32.6%

SNGX29.9%

Asset Turnover (TTM)

BOLT0.09x

SNGX0.05x

FCF Yield (TTM)

BOLT-399.6%

SNGX-180.8%

Earnings Yield (TTM)

BOLT-364.2%

SNGX-190.0%

Dividend Yield (TTM)

BOLTN/A

SNGXN/A

Rule of 40

BOLT-658.2

SNGX0.0

EV/GP/RG

BOLTN/A

SNGXN/A

Ticker research

View BOLT research View SNGX research

Metric	BOLT Bolt Biotherapeutics Inc	SNGX Soligenix Inc
Market & Valuation
Market Cap	$8M	$5M
Enterprise Value	$-5M	$-4M
Price	$4.11	$0.36
P/E Ratio	N/A	N/A
P/S Ratio	1.68x	16.09x
EV/Sales	-1.06x	-3.76x
EV/EBITDA	0.00x	-1.54x
P/B Ratio	0.53x	1.20x
P/FCF Ratio	N/A	N/A
EV/FCF	0.16x	0.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	12.8%	N/A
Forward Rev Growth	1650.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	8.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-586.3%	0.0%
Net Margin (TTM)	-611.5%	0.0%
FCF Margin (TTM)	-671.0%	N/A
Net Income (TTM)	$-29M	$-10M
FCF (TTM)	$-32M	$-10M
EPS (TTM)	-$17.00	-$0.64
ROE (TTM)	-12623.0%	-18102.0%
ROA (TTM)	-5470.0%	-10792.0%
ROIC (TTM)	-12623.0%	-18102.0%
Financial Health
Cash	$13M	$10M
Debt	$0	$0
Net Cash/Debt	$13M	$10M
Current Ratio (TTM)	2.61x	2.77x
Quick Ratio (TTM)	2.26x	2.67x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	2.15
52W Performance	-35.8%	-79.9%
YTD Performance	-29.0%	-74.4%
% from 52W High	-42.9%	-81.5%
% from 52W Low	32.6%	29.9%
Efficiency & Yields
Asset Turnover (TTM)	0.09x	0.05x
FCF Yield (TTM)	-399.6%	-180.8%
Earnings Yield (TTM)	-364.2%	-190.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-658.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BOLT research	View SNGX research

Valuation

P/S Ratio

BOLT

1.68x

SNGX

16.09x

EV/FCF

BOLT

0.16x

SNGX

0.45x

Growth & revenue

Revenue Growth TTM

BOLT

12.8%

Forward Revenue Growth

BOLT

1650.0%

SNGX

0.0%

Profitability & performance

Gross Margin

SNGX

8.8%

BOLT

0.0%

ROE

BOLT

-12623.0%

SNGX

-18102.0%

FCF Yield %

SNGX

-180.8%

BOLT

-399.6%

52-Week Performance

BOLT

-35.8%

SNGX

-79.9%

Detailed metrics comparison

BOLT

Bolt Biotherapeutics Inc

SNGX

Soligenix Inc

Market Cap

BOLT$8M

SNGX$5M

Enterprise Value

BOLT$-5M

SNGX$-4M

Price

BOLT$4.11

SNGX$0.36

P/E Ratio

BOLTN/A

SNGXN/A

P/S Ratio

BOLT1.68x

SNGX16.09x

EV/Sales

BOLT-1.06x

SNGX-3.76x

EV/EBITDA

BOLT0.00x

SNGX-1.54x

P/B Ratio

BOLT0.53x

SNGX1.20x

P/FCF Ratio

BOLTN/A

SNGXN/A

EV/FCF

BOLT0.16x

SNGX0.45x

PEG Ratio

BOLTN/A

SNGXN/A

Forward P/E (NTM)

BOLTN/A

SNGXN/A

Forward P/S (NTM)

BOLTN/A

SNGXN/A

Revenue (TTM)

BOLT$5M

SNGX$0

Revenue Growth (YoY)

BOLT12.8%

SNGXN/A

Forward Rev Growth

BOLT1650.0%

SNGX0.0%

Gross Margin (TTM)

BOLT0.0%

SNGX8.8%

Operating Margin (TTM)

BOLT0.0%

SNGX0.0%

EBITDA Margin (TTM)

BOLT-586.3%

SNGX0.0%

Net Margin (TTM)

BOLT-611.5%

SNGX0.0%

FCF Margin (TTM)

BOLT-671.0%

SNGXN/A

Net Income (TTM)

BOLT$-29M

SNGX$-10M

FCF (TTM)

BOLT$-32M

SNGX$-10M

EPS (TTM)

BOLT-$17.00

SNGX-$0.64

ROE (TTM)

BOLT-12623.0%

SNGX-18102.0%

ROA (TTM)

BOLT-5470.0%

SNGX-10792.0%

ROIC (TTM)

BOLT-12623.0%

SNGX-18102.0%

Cash

BOLT$13M

SNGX$10M

Debt

BOLT$0

SNGX$0

Net Cash/Debt

BOLT$13M

SNGX$10M

Current Ratio (TTM)

BOLT2.61x

SNGX2.77x

Quick Ratio (TTM)

BOLT2.26x

SNGX2.67x

Debt/Equity (TTM)

BOLT0.00x

SNGX0.00x

Debt/Assets (TTM)

BOLT0.0%

SNGX0.0%

Interest Coverage (TTM)

BOLTN/A

SNGXN/A

Net Debt/EBITDA (TTM)

BOLT0.00x

SNGX0.00x

Beta

BOLT0.97

SNGX2.15

52W Performance

BOLT-35.8%

SNGX-79.9%

YTD Performance

BOLT-29.0%

SNGX-74.4%

% from 52W High

BOLT-42.9%

SNGX-81.5%

% from 52W Low

BOLT32.6%

SNGX29.9%

Asset Turnover (TTM)

BOLT0.09x

SNGX0.05x

FCF Yield (TTM)

BOLT-399.6%

SNGX-180.8%

Earnings Yield (TTM)

BOLT-364.2%

SNGX-190.0%

Dividend Yield (TTM)

BOLTN/A

SNGXN/A

Rule of 40

BOLT-658.2

SNGX0.0

EV/GP/RG

BOLTN/A

SNGXN/A

Ticker research

View BOLT research View SNGX research

Metric	BOLT Bolt Biotherapeutics Inc	SNGX Soligenix Inc
Market & Valuation
Market Cap	$8M	$5M
Enterprise Value	$-5M	$-4M
Price	$4.11	$0.36
P/E Ratio	N/A	N/A
P/S Ratio	1.68x	16.09x
EV/Sales	-1.06x	-3.76x
EV/EBITDA	0.00x	-1.54x
P/B Ratio	0.53x	1.20x
P/FCF Ratio	N/A	N/A
EV/FCF	0.16x	0.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	12.8%	N/A
Forward Rev Growth	1650.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	8.8%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-586.3%	0.0%
Net Margin (TTM)	-611.5%	0.0%
FCF Margin (TTM)	-671.0%	N/A
Net Income (TTM)	$-29M	$-10M
FCF (TTM)	$-32M	$-10M
EPS (TTM)	-$17.00	-$0.64
ROE (TTM)	-12623.0%	-18102.0%
ROA (TTM)	-5470.0%	-10792.0%
ROIC (TTM)	-12623.0%	-18102.0%
Financial Health
Cash	$13M	$10M
Debt	$0	$0
Net Cash/Debt	$13M	$10M
Current Ratio (TTM)	2.61x	2.77x
Quick Ratio (TTM)	2.26x	2.67x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.97	2.15
52W Performance	-35.8%	-79.9%
YTD Performance	-29.0%	-74.4%
% from 52W High	-42.9%	-81.5%
% from 52W Low	32.6%	29.9%
Efficiency & Yields
Asset Turnover (TTM)	0.09x	0.05x
FCF Yield (TTM)	-399.6%	-180.8%
Earnings Yield (TTM)	-364.2%	-190.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-658.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BOLT research	View SNGX research